Properties of human foamy virus relevant to its development as a vector for gene therapy
about
Restriction of foamy viruses by APOBEC cytidine deaminasesHistorical perspective of foamy virus epidemiology and infectionEarly steps of retrovirus replicative cycleRetroviral superinfection resistance.Progresses towards safe and efficient gene therapy vectorsFoamy virus biology and its application for vector developmentDiscovery of prosimian and afrotherian foamy viruses and potential cross species transmissions amidst stable and ancient mammalian co-evolutionNon-simian foamy viruses: molecular virology, tropism and prevalence and zoonotic/interspecies transmissionPotential of zoonotic transmission of non-primate foamy viruses to humans.Multiple blocks to human immunodeficiency virus type 1 replication in rodent cellsBovine foamy virus transactivator BTas interacts with cellular RelB to enhance viral transcriptionFoamy virus vector integration sites in normal human cellsLentivirus and foamy virus vectors: novel gene therapy tools.Foamy virus for efficient gene transfer in regeneration studiesApplication of chimeric feline foamy virus-based retroviral vectors for the induction of antiviral immunity in cats.Advances in foamy virus vector technology and disease correction could speed the path to clinical applicationCocirculation of Two env Molecular Variants, of Possible Recombinant Origin, in Gorilla and Chimpanzee Simian Foamy Virus Strains from Central Africa.Large animal models for foamy virus vector gene therapy.Foamy virus infection in primates.Infectious Entry Pathway Mediated by the Human Endogenous Retrovirus K Envelope Protein.Cell cycle requirements for transduction by foamy virus vectors compared to those of oncovirus and lentivirus vectors.Species-specific inhibition of APOBEC3C by the prototype foamy virus protein betRapid and Efficient Stable Gene Transfer to Mesenchymal Stromal Cells Using a Modified Foamy Virus Vector.Foamy virus vectors for gene transfer.Molecular biology of foamy viruses.Early events in foamy virus-host interaction and intracellular traffickingFeline foamy virus-based vectors: advantages of an authentic animal model.A small-molecule-controlled system for efficient pseudotyping of prototype foamy virus vectorsInnate sensing of foamy viruses by human hematopoietic cells.A new indicator cell line established to monitor bovine foamy virus infection.Isolation and characterization of an equine foamy virus.Efficacy of dideoxynucleosides against human foamy virus and relationship to its reverse transcriptase amino acid sequence and structure.Novel functions of prototype foamy virus Gag glycine- arginine-rich boxes in reverse transcription and particle morphogenesis.Analysis of prototype foamy virus particle-host cell interaction with autofluorescent retroviral particles.Analysis of bovine foamy virus btas mRNA transcripts during persistent infection.Transduction of human neural progenitor cells with foamy virus vectors for differentiation-dependent gene expression.Establishment of an indicator cell line to quantify bovine foamy virus infection.Correct capsid assembly mediated by a conserved YXXLGL motif in prototype foamy virus Gag is essential for infectivity and reverse transcription of the viral genome.The fourth central polypurine tract guides the synthesis of prototype foamy virus plus-strand DNA.Stable inhibition of hepatitis B virus proteins by small interfering RNA expressed from viral vectors.
P2860
Q24299944-1AF81B8C-1010-4222-9901-AA8EC73136BCQ24550692-27F301D6-5538-4B60-A231-A7CECE37C990Q24792862-88F09106-D669-4A72-AA25-8DD30848FECEQ24815564-76DC829B-2FFF-499D-A2FE-41B2F45D1CAAQ26781432-F321B4D1-4862-4010-AE28-77173D23F42EQ26864134-37AA85A9-A7CF-4DC5-8BBD-6D3ADAA74F6BQ28650068-BE4AC1D9-FDE4-4441-9592-7D58D57AEA80Q28673358-83823198-9689-4EC9-B8C0-D22A8814A793Q30336260-8116EF26-7D50-4BDC-B703-E6CABB9632FDQ33603453-DAFD472C-0163-4220-AFC3-9F66383B7ED3Q34295911-1056474E-1C96-432A-8BD0-481BE73FFDCEQ34334976-623C682C-FDE6-463A-9D27-3DB4D083158DQ34452109-36D89BCD-DA2D-4625-90EF-73D191F7F49BQ34704560-CFEC7AAB-19DE-4F83-930E-E565EBA1BC26Q35104790-325486B6-F684-46DE-B9EF-573AD5C8D167Q36014053-65EF4250-7A4D-4A90-981C-718E69BBD236Q36334380-85F8D3BF-304C-47F2-A471-6E4131CDD9F3Q36482767-BE1EFDB9-F106-442C-AB93-17322A52F672Q36548744-6A361530-1951-44DA-89EB-BB30C1CC19D9Q36694049-50B210AC-2E82-437D-A562-A798CDDA134CQ36954062-CE7294D0-E98A-443A-A9FE-9FB1E5DF3422Q37104705-B364A2DA-DFB8-401C-93F2-DFEED4BD945DQ37170654-353203D1-A248-4588-A063-9CF6DA3D598DQ37594766-3863086C-21B3-4831-B2A9-8FCAB837414BQ37743255-541E8FE5-04CA-4675-A194-48DBF2A6CD46Q38097291-8E72C41E-3564-4294-9FF2-624E7251B5BBQ38121801-F8943981-65AC-4AA5-B72E-EC53231977FBQ39369916-B77C14AB-D254-42D5-8BA4-340E04FB655FQ39441971-C95414C3-2CCA-49C8-8B21-7AFDF547E924Q39462032-9856A306-AED9-43EE-ACDA-825C2C04046CQ39590740-1AD59EBA-3585-4DE3-B98B-6B670C41D29EQ39603905-E537F2BC-579D-4587-A276-D3D5EAF6764EQ39627850-0FB28DE6-4402-4EC4-A5CE-A732AE33B043Q39703179-EF8B7954-28E3-4EB5-ADF8-0F2C6EE20EADQ39775287-E8A91FD0-EDF5-4502-94EB-432B4BBD3432Q39909504-E8F3EE8C-B51D-4838-AD80-521E6C048AFDQ39948199-8C119DA6-F0BE-4F92-ADC8-C4570A060C73Q40182244-9FA84254-3533-47FA-BFD6-8542BC0D1018Q40337891-730577A4-9717-443A-BCF2-731CC92C025FQ40448653-7510009A-9A9C-424C-8C10-0F65BE8107A6
P2860
Properties of human foamy virus relevant to its development as a vector for gene therapy
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Properties of human foamy virus relevant to its development as a vector for gene therapy
@ast
Properties of human foamy virus relevant to its development as a vector for gene therapy
@en
Properties of human foamy virus relevant to its development as a vector for gene therapy
@nl
type
label
Properties of human foamy virus relevant to its development as a vector for gene therapy
@ast
Properties of human foamy virus relevant to its development as a vector for gene therapy
@en
Properties of human foamy virus relevant to its development as a vector for gene therapy
@nl
prefLabel
Properties of human foamy virus relevant to its development as a vector for gene therapy
@ast
Properties of human foamy virus relevant to its development as a vector for gene therapy
@en
Properties of human foamy virus relevant to its development as a vector for gene therapy
@nl
P2093
P3181
P1476
Properties of human foamy virus relevant to its development as a vector for gene therapy
@en
P2093
M O McClure
P D Bieniasz
P304
P3181
P356
10.1099/0022-1317-80-8-2003
P407
P478
80 ( Pt 8)
P577
1999-08-01T00:00:00Z